Trials / Completed
CompletedNCT04887181
The Effects of Different Dentin Hypersensitivity Treatment Methods on Quality of Life
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Kırıkkale University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study was to evaluate the effects of a self etch adhesive resin and two desensitizing agents(Calcium phosphate, 5% glutaraldehyde) in treatment of dentin hypersensitivity on the quality of life of individuals.
Detailed description
This in-vivo study was done among 69 participants who reported at least one sensitivite tooth(Schiff Sensitivity Score \>1) as a result of the clinical examination. Participants were randomly divided into three treatment groups(n=23): I. Tetracalcium phosphate and dicalcium phosphate containing desensitizer (Teethmate Desensitizer) II. %35 hydroxyethyl methacrylate and %5 glutaraldehyde containing desensitizer (Gluma Desensitizer) III. Self-etch adhesive resin (Hybrid Bond) These materials used in treatment of dentin hypersensitivity in 6 months clinical follow-up and the effects on the quality of life of individuals were evaluated with Dentine Hypersensitivity Experience Questionnaire (DHEQ).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Teethmate Desensitizer | Powder and liquid contained in the material were mixed. It was applied to the buccal surface of the sensitive tooth. then it was washed away from the tooth surface. 1-4 sessions were applied until the sensitivity disappeared. |
| OTHER | Gluma Desensitizer | The material was applied to the buccal surface of the tooth with sensitivity. It was washed with water and removed from the tooth surface. 1-4 sessions were applied until the sensitivity disappeared. |
| OTHER | Hybrid Bond | It was applied to the buccal surface of the sensitive tooth with an applicator. It was cured with a LED light device. Dentin sensitivity was checked with evaporative air application. The process was repeated until the sensitivity disappeared. |
Timeline
- Start date
- 2020-03-04
- Primary completion
- 2020-09-04
- Completion
- 2021-03-01
- First posted
- 2021-05-14
- Last updated
- 2021-05-14
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04887181. Inclusion in this directory is not an endorsement.